1. Home
  2. ACB vs APYX Comparison

ACB vs APYX Comparison

Compare ACB & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Cannabis Inc.

ACB

Aurora Cannabis Inc.

HOLD

Current Price

$3.54

Market Cap

188.3M

Sector

Health Care

ML Signal

HOLD

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$3.14

Market Cap

159.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACB
APYX
Founded
2013
1982
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.3M
159.0M
IPO Year
2016
1995

Fundamental Metrics

Financial Performance
Metric
ACB
APYX
Price
$3.54
$3.14
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.50
AVG Volume (30 Days)
1.4M
168.9K
Earning Date
06-17-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
19.40
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.31
$11.93
Revenue Next Year
N/A
$11.01
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.07
$1.12
52 Week High
$6.67
$4.50

Technical Indicators

Market Signals
Indicator
ACB
APYX
Relative Strength Index (RSI) 52.44 37.56
Support Level $3.22 $2.83
Resistance Level $3.91 $3.27
Average True Range (ATR) 0.21 0.24
MACD 0.00 -0.09
Stochastic Oscillator 33.33 27.04

Price Performance

Historical Comparison
ACB
APYX

About ACB Aurora Cannabis Inc.

Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

Share on Social Networks: